These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8180257)

  • 1. Case report of an inhibitor patient treated with recombinant factor VIII.
    Kim H
    Ann Hematol; 1994; 68 Suppl 3():S37. PubMed ID: 8180257
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor VIII inhibitor and severity of hemophilia.
    Schoppmann A; Waytes AT
    Thromb Haemost; 1996 Aug; 76(2):280-1. PubMed ID: 8865549
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid elimination of a high-titered F VIII inhibitor by high dose recombinant F VIII combined with high dose immunoglobulin infusion.
    Mauz-Korholz C; Korholz D; Gobel U
    Thromb Haemost; 1997 Aug; 78(2):959. PubMed ID: 9268203
    [No Abstract]   [Full Text] [Related]  

  • 4. A 3.5-year study of immune function in persons with hemophilia infusing recombinant factor VIII.
    Brettler D
    Ann Hematol; 1994; 68 Suppl 3():S49-50. PubMed ID: 7910039
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitor questions: plasma-derived factor VIII and recombinant factor VIII.
    Bray G
    Ann Hematol; 1994; 68 Suppl 3():S29-34. PubMed ID: 8180254
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
    Hedner U
    Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemophilia with factor VIII inhibitor. Elimination of anamnestic response.
    Stein RS; Colman RW
    Ann Intern Med; 1973 Jul; 79(1):84-7. PubMed ID: 4124485
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant factor VIII in hemophilia.
    Cohen A; Butler R
    N Engl J Med; 1991 May; 324(21):1515-6. PubMed ID: 1902552
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials of the recombinant factor VIII product, Kogenate.
    Inwood M; Lusher J
    Transfus Med Rev; 1992 Oct; 6(4):261-2. PubMed ID: 1421826
    [No Abstract]   [Full Text] [Related]  

  • 10. Who should use recombinant factor VIII?
    Hoots K
    Ann Hematol; 1994; 68 Suppl 3():S65-8. PubMed ID: 8180258
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
    Monahan PE; Aledort LM;
    Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant factor VIII. An introduction to recombinant DNA technology and the first results published in the replacement treatment of hemophilia A].
    Juárez Giménez JC; Montoro Ronsano JB; Tusell JM
    Med Clin (Barc); 1994 Nov; 103(15):591-5. PubMed ID: 7990527
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychosocial issues surrounding the general or restricted use of recombinant factor VIII: hemophilia clinic perspective.
    McDonald JR
    Transfus Med Rev; 1992 Oct; 6(4):277-9. PubMed ID: 1421829
    [No Abstract]   [Full Text] [Related]  

  • 14. Factor VIII assays in haemophilia a patients treated with ReFacto.
    Sukhu K; Harrison P; Keeling D
    Br J Haematol; 2003 Apr; 121(2):379-80. PubMed ID: 12694265
    [No Abstract]   [Full Text] [Related]  

  • 15. The past and the future: recombinant factor VIII and the consumer.
    Isaac BM
    Transfus Med Rev; 1992 Oct; 6(4):280-3. PubMed ID: 1421830
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of recombinant factor VIII in the management of hemophilia.
    Mannucci PM; Gringeri A; Cattaneo M
    Curr Stud Hematol Blood Transfus; 1991; (58):46-51. PubMed ID: 1954773
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune tolerance in hemophilia and the treatment of hemophiliacs with an inhibitor. Proceedings of a meeting. Palermo, Italy, October 1999.
    Haematologica; 2000 Oct; 85(10 Suppl):1-116. PubMed ID: 11236744
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and introduction of recombinant factor VIII--a clinician's experience.
    Lusher JM
    Haemophilia; 2012 Jul; 18(4):483-6. PubMed ID: 22512315
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitor development in prospective clinical trials with recombinant factor VIII preparations in previously untreated patients.
    Lusher JM
    Vox Sang; 1999; 77 Suppl 1():9. PubMed ID: 10529677
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of acquired haemophilia with recombinant porcine factor VIII: A successful strategy in a patient with unstable angina.
    Owen M; Gidley G; Horn EH
    Haemophilia; 2019 Mar; 25(2):e94-e97. PubMed ID: 30604899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.